Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Director/PDMR Shareholding

17 Jan 2018 07:00

RNS Number : 0601C
Sinclair Pharma PLC
17 January 2018
 

Sinclair Pharma plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

London, 17 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, was advised on 16 January 2018, that on that day, Jeff Thompson, Non-Executive Director, acquired 200,000 ordinary shares of 1p each ("Ordinary Shares") in the Group at an average price of 23.1p per Ordinary Share.

Following these purchases, Jeff Thompson's total beneficial interest is 350,000 Ordinary Shares, 0.07% of the issued share capital of the Group.

For further information please contact:

Sinclair Pharma plc

Tel: +44 (0) 20 7467 6920

Chris Spooner 

Alan Olby

Andy Crane

 

Peel Hunt LLP (NOMAD and Joint Broker)

Tel: +44 (0) 20 7418 8900

James Steel

Oliver Jackson

 

RBC Capital Markets (Joint Broker)

Tel: +44 (0) 20 7653 4000

Marcus Jackson

Laura White

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jeff Thompson

2.

Reason for the notification

a.

Position/status

Non-Executive Director

b.

Initial notification

/Amendment

Initial Announcement

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Sinclair Pharma plc

b.

LEI

213800BNMD7JVMHW1772

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary Shares of 1 pence each in Sinclair Pharma plc

 

 

 

GB0033856740

b.

Nature of the transaction

Purchase

 

c.

Price(s) and volume(s)

 Price(s)

 

Volume(s)

23.1p

200,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

N/A

 

e.

Date of the transaction

2018-01-16

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDQLFFVFFLBBD
Date   Source Headline
26th Nov 20142:25 pmRNSForm 8.3 - Sinclair IS Pharma plc
25th Nov 20143:56 pmRNSAppointment of General Counsel
25th Nov 20141:57 pmBUSForm 8.3 - Sinclair IS Pharma plc
25th Nov 201412:11 pmRNSResult of AGM
25th Nov 20147:00 amRNSStatement re AGM and commencement of offer period
20th Nov 20143:41 pmRNSHolding(s) in Company
20th Nov 20143:34 pmRNSHolding(s) in Company
19th Nov 20143:20 pmRNSHolding(s) in Company
5th Nov 20149:02 amRNSHolding(s) in Company
31st Oct 20142:31 pmRNSAnnual Financial Report
29th Oct 20147:30 amRNSHolding(s) in Company
17th Oct 20143:56 pmRNSDirector/PDMR Shareholding
16th Oct 20141:00 pmRNSDirector/PDMR Shareholding - Replacement
15th Oct 20147:30 amRNSDirector/PDMR Shareholding
18th Sep 20147:00 amRNSDirectorate Change
18th Sep 20147:00 amRNSPreliminary results
8th Sep 201410:00 amRNSNotice of Results
18th Jul 201410:13 amRNSDirector/PDMR Shareholding
17th Jul 201411:00 amRNSShare Awards
15th Jul 20147:00 amRNSTrading Statement
10th Jul 20144:35 pmRNSPrice Monitoring Extension
9th Jul 201411:07 amRNSHolding(s) in Company
25th Jun 20148:40 amRNSDirector/PDMR Shareholding
10th Jun 20147:30 amRNSDirector/PDMR Shareholding
13th May 20147:30 amRNSHolding(s) in Company
8th May 20147:30 amRNSHolding(s) in Company
8th May 20147:30 amRNSDirector/PDMR Shareholding
7th May 20144:54 pmRNSHolding(s) in Company
7th May 20147:30 amRNSHolding(s) in Company
6th May 20141:32 pmRNSHolding(s) in Company
6th May 20147:30 amRNSDirector/PDMR Shareholding
2nd May 20149:30 amRNSDirector/PDMR Shareholding
2nd May 20147:34 amRNSDirector/PDMR Shareholding
1st May 201410:50 amRNSResult of General Meeting
1st May 20147:30 amRNSDirector/PDMR Shareholding
30th Apr 20147:30 amRNSDirector/PDMR Shareholding
28th Apr 20147:30 amRNSDirector/PDMR Shareholding
25th Apr 201411:04 amRNSDirector/PDMR Shareholding
25th Apr 20147:00 amRNSAcquisition of Perfectha distribution rights
23rd Apr 20149:13 amRNSDirector/PDMR Shareholding
22nd Apr 201410:22 amRNSDirector/PDMR Shareholding
17th Apr 20145:09 pmRNSDirector/PDMR Shareholding
16th Apr 201410:56 amRNSPosting of Shareholder Circular
15th Apr 20144:20 pmRNSAcquisition and placing
8th Apr 20147:00 amRNSHolding(s) in Company
31st Mar 20143:14 pmRNSHolding(s) in Company
28th Mar 20147:36 amRNSHolding(s) in Company
28th Mar 20147:02 amRNSHolding(s) in Company
25th Mar 20147:00 amRNSAcquisition of Global Rights to Ellansé
25th Mar 20147:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.